{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:05:23Z","timestamp":1784696723817,"version":"3.55.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,18]]},"DOI":"10.1093\/ibd\/izy008","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T01:56:50Z","timestamp":1525399010000},"page":"1107-1113","source":"Crossref","is-referenced-by-count":21,"title":["Outcomes of Perianal Fistulising Crohn\u2019s Disease Following Anti-TNF\u03b1 Treatment Discontinuation"],"prefix":"10.1093","volume":"24","author":[{"given":"Cl\u00e9mence","family":"Legu\u00e9","sequence":"first","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Brochard","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"},{"name":"Inserm 991, University of Rennes, France"},{"name":"CIC1414, Universit\u00e9 de Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Bessi","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Wallenhorst","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dewitte","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Siproudhis","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"},{"name":"Inserm 991, University of Rennes, France"},{"name":"CIC1414, Universit\u00e9 de Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bouguen","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology, University Hospital of Pontchaillou, Rennes, France"},{"name":"Inserm 991, University of Rennes, France"},{"name":"CIC1414, Universit\u00e9 de Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"key\n\t\t\t\t20180518102836_CIT0001","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0016-5085(98)70420-2","article-title":"Clinical course of colorectal Crohn\u2019s disease: a 35-year follow-up study of 507 patients","volume":"114","author":"Lapidus","year":"1998","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180518102836_CIT0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3748\/wjg.v12.i1.75","article-title":"Crohn\u2019s disease in stockholm county during 1990-2001: an epidemiological update","volume":"12","author":"Lapidus","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180518102836_CIT0003","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180518102836_CIT0004","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180518102836_CIT0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180518102836_CIT0006","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1556\/OH.2013.29770","article-title":"Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn\u2019s disease","volume":"154","author":"Bor","year":"2013","journal-title":"Orv Hetil"},{"key":"key\n\t\t\t\t20180518102836_CIT0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180518102836_CIT0008","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"58","author":"Colombel","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180518102836_CIT0009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180518102836_CIT0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-tnf\u03b1 therapy: results from the COIN study","volume":"63","author":"van der Valk","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180518102836_CIT0011","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180518102836_CIT0012","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn\u2019s disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180518102836_CIT0013","first-page":"949","article-title":"Infliximab therapy for Crohn\u2019s disease anoperineal lesions","volume":"25","author":"Ouraghi","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"key\n\t\t\t\t20180518102836_CIT0014","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180518102836_CIT0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","article-title":"Long-term treatment of rectovaginal fistulas in crohn\u2019s disease: response to infliximab in the ACCENT II study","volume":"2","author":"Sands","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180518102836_CIT0016","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180518102836_CIT0017","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/00365521.2015.1079924","article-title":"Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation","volume":"51","author":"Bortlik","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20180518102836_CIT0018","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180518102836_CIT0019","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn\u2019s disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180518102836_CIT0020","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn\u2019s perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180518102836_CIT0021","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","article-title":"Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn\u2019s perianal fistulas","volume":"18","author":"Tozer","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180518102836_CIT0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ibd.21405","article-title":"Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn\u2019s disease: results from a prospective study","volume":"17","author":"Roumegu\u00e8re","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180518102836_CIT0023","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/apt.12160","article-title":"Predictors of relapse in patients with Crohn\u2019s disease in remission after 1 year of biological therapy","volume":"37","author":"Moln\u00e1r","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180518102836_CIT0024","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/MEG.0b013e32835558cf","article-title":"Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis","volume":"24","author":"Lee","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/6\/1107\/24831292\/izy008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:28:19Z","timestamp":1571304499000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/6\/1107\/4992664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,5,4]]},"published-print":{"date-parts":[[2018,5,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy008","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,5,4]]}}}